Acute Kidney Injury (AKI) & NINJA

Empower your hospital to easily monitor patients that meet the NINJA protocol and intervene early to improve patient care and outcomes.

Cincinnati Children’s

Cincinnati Childrens Logo

In collaboration with Cincinnati Children’s, leveraging their groundbreaking research on pediatric nephrotoxic kidney injury: Nephrotoxic Injury Negated by Just-in-time Action (NINJA)

Benefits

  • Identifies the earliest possible intervention opportunity in real time
  • Customizes metric outputs with respect to service lines and time periods
  • Automatic and customizable data extraction for all metric elements, including inpatient census by location or service line
  • Leverages platform for other sites for inter-site benchmarking data, as well as development of prospective interventional studies
  • Trends conditions over time via automated run charts
  • Decreases IT time and cost for implementation for manual or alternative monitoring solutions
  • Integrates with all major EHR platforms
  • Offered as a stand-alone solution or combined with other VigiLanz core products

NINJA surveillance algorithm built within VigiLanz

Nephrotoxic (NTMx) Patient Exposure Criteria:

  • ≥3 NTMx medications from list of 57 medications OR
  • ≥3 days on any IV AG OR
  • ≥3 days on Vancomycin

AKI Criteria for NTMX Exposed Patients:

  1. 1. At least 50% increase in Serum Creatinine (SCr) above patient baseline (lowest SCr in the past 6 months), with the increase value above a threshold of 0.5 mg/dL
  2. 2. An absolute increase of 0.3 mg/dL in SCr within 48 hours, regardless of the maximum value